HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Antiemetic and antinauseant effect of alizapride in patients subjected to antiblastic infusion chemotherapy in a day-hospital regime].

Abstract
A study about alizapride in out patients with nausea and vomiting during infusional antiblastic chemotherapy.
AuthorsF Cicchetti, P Viganò, C M Borghi, A Franzini, G Alfano, C Antolini
JournalGiornale italiano di oncologia (G Ital Oncol) 1989 Jan-Mar Vol. 9 Issue 1 Pg. 18-21 ISSN: 0392-128X [Print] Italy
Vernacular TitleStudio dell'azione antiemetica e antinausea dell'alizapride nei pazienti sottoposti a chemioterapia antiblastica infusionale in regime di day-hospital.
PMID2707835 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antiemetics
  • Antineoplastic Agents
  • Pyrrolidines
  • alizapride
Topics
  • Aged
  • Antiemetics (therapeutic use)
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Female
  • Humans
  • Infusions, Parenteral
  • Male
  • Middle Aged
  • Nausea (chemically induced, drug therapy)
  • Pyrrolidines (therapeutic use)
  • Urinary Bladder Neoplasms (drug therapy)
  • Vomiting (chemically induced, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: